Janux Therapeutics, Inc. (JANX)
13.88
+0.30
(+2.21%)
USD |
NASDAQ |
Mar 16, 16:00
13.68
-0.20
(-1.44%)
After-Hours: 05:02
Janux Therapeutics Total Liabilities (Quarterly) : 50.70M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 71.53B |
| MannKind Corp. | 843.20M |
| EyePoint Plc | 57.88M |
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| CorMedix, Inc. | 472.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.008B |
| Shareholders Equity (Quarterly) | 956.82M |
| Debt to Equity Ratio | 0.0231 |
| Current Ratio | 39.04 |
| Net Debt Paydown Yield | 0.03% |